Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Lamivudine & Zidovudine bulk supplier for pharma manufacturers

Lamivudine & Zidovudine Suppliers & Bulk Manufacturers

Available Forms: Tablet

Available Strengths: Lamivudine 150 mg + Zidovudine 300 mg

Reference Brands: Combivir®(US/ EU)

Category: Anti Viral

Lamivudine & Zidovudine Tablets (150 mg/300 mg) offer a fixed-dose antiretroviral for HIV treatment. Available through PharmaB2B from certified manufacturers, it's ideal for tenders, NGOs, and hospital procurement. Ensure compliant, bulk sourcing from WHO-GMP and USFDA-approved suppliers to support reliable HIV therapy access globally.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Lamivudine & Zidovudine Tablets are a fixed-dose combination of two key NRTIs used in the management of HIV-1 infection. Each tablet contains Lamivudine 150 mg and Zidovudine 300 mg, offering dual-action antiviral activity in a convenient dosing format. Available under brands like Combivir®, this formulation is widely used in global HIV treatment protocols. Through PharmaB2B platforms, healthcare providers and procurement agencies can access bulk supplies from WHO-GMP and USFDA-approved manufacturers. Ideal for tenders, NGOs, and institutional buyers, this ARV combo supports consistent, cost-effective treatment. Connect with trusted suppliers to ensure high-quality antiretrovirals and uninterrupted patient care.

Lamivudine & Zidovudine — third party manufacturing & bulk supply

Lamivudine & Zidovudine is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Lamivudine & Zidovudine is supplied as Tablet — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Lamivudine & Zidovudine listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Lamivudine & Zidovudine →
Back to Listing

Frequently Asked Questions

Lamivudine and zidovudine are used together to treat HIV-1 infection. This fixed-dose combination helps reduce viral load, improve immune function, and slow the progression of HIV as part of combination antiretroviral therapy.

It is made from two nucleoside reverse transcriptase inhibitors (NRTIs): lamivudine, a synthetic cytidine analogue, and zidovudine, a thymidine analogue. Together, they block viral replication by inhibiting the HIV reverse transcriptase enzyme.

The most common trade name is Combivir.

Combivir is manufactured by GlaxoSmithKline (GSK) and ViiV Healthcare, with additional production by global generic pharmaceutical companies.

The generic name is lamivudine and zidovudine.

The primary brand name is Combivir.

It is manufactured in approved facilities in the UK, USA, Europe, and India, depending on the manufacturer and regulatory approvals for each region.

Related Products

Efavirenz + Emtricitabine + Tdf

Strength:
600/200/300 mg

Form: Tablet

Reference Brands: Atripla(US/EU)

View Details
Lamivudine

Strength:
Tab:150 mg, 300 mg; Oral solution:10 mg/mL

Form: Tablet & Oral solution

Reference Brands: Epivir®(US/EU)

View Details
Efavirenz

Strength:
Tab: 200 mg, 600 mg; Cap: 50 mg, 100 mg, 200 mg

Form: Tablet & Capsule

Reference Brands: Sustiva®(US); Stocrin®(EU)

View Details
Nelfinavir Mesylate

Strength:
Tablets: 250 mg, 625 mg: Oral Powder: 50 mg/g

Form: Tablet & Oral Powder

Reference Brands: Viracept®

View Details
Nelfinavir Mesylate Tablets

Strength:
625 mg

Form: Tablets

Reference Brands: Viracept (USA/EU/UK)

View Details
Ritonavir & Lopinavir Tablets

Strength:
50mg + 200 mg

Form: Tablets

Reference Brands: Kaletra (USA/EU)

View Details
Atazanavir Capsules

Strength:
100 mg, 200 mg, 300 mg

Form: Capsules

Reference Brands: Reyataz (USA/EU/UK)

View Details
Didanosine Capsules

Strength:
250 mg, 400 mg

Form: Capsules

Reference Brands: Videx EC (USA/EU)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.